Srinivasan Vedantham to Glycation End Products, Advanced
This is a "connection" page, showing publications Srinivasan Vedantham has written about Glycation End Products, Advanced.
Connection Strength
1.053
-
Rajaraman B, Ramadas N, Krishnasamy S, Ravi V, Pathak A, Devasena CS, Swaminathan K, Ganeshprasad A, Kuppuswamy AA, Vedantham S. Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus. Mol Cell Biochem. 2019 Jun; 456(1-2):179-190.
Score: 0.616
-
Bai MR, Abirami K, Gayathri R, Vedantham S, Shobana S, Nagarajan LP, Gunasekaran G, Nagamuthu G, Malini HM, Gokulakrishnan K, Sandhya N, Ganesh Jeevan R, Anjana RM, Unnikrishnan R, Krishnaswamy K, Sudha V, Mohan V. Effect of low vs high dietary-advanced glycation end products on insulin-sensitivity and inflammatory- markers among overweight/obese Asian-Indian adults-A randomised controlled trial. Int J Food Sci Nutr. 2024 Dec; 75(8):835-845.
Score: 0.228
-
Krishnasamy S, Ravi V, Rajaraman B, Kumar Thulasingam S, Dhevasena CS, Pathak A, Swaminathan K, Sundaresan M, Ayyappa KA, Arunkumar G, Kuppan G, Ramadas N, Vedantham S. Role of VEGF165b/VEGFTOTAL ratio in gestational diabetes mellitus. Gynecol Endocrinol. 2019 Sep; 35(9):811-814.
Score: 0.156
-
Kumar P, Nesakumar N, Gopal J, Sivasubramanian S, Vedantham S, Rayappan JBB. Clinical validation of electrochemical biosensor for the detection of methylglyoxal in subjects with type-2 diabetes mellitus. Bioelectrochemistry. 2024 Feb; 155:108601.
Score: 0.053